A detailed history of Jfs Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 1,305 shares of NVO stock, worth $108,406. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,305
Previous 1,307 0.15%
Holding current value
$108,406
Previous $186,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$119.07 - $145.42 $238 - $290
-2 Reduced 0.15%
1,305 $155,000
Q2 2024

Jul 15, 2024

SELL
$122.71 - $146.91 $490 - $587
-4 Reduced 0.31%
1,307 $186,000
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $7,022 - $8,436
-80 Reduced 5.75%
1,311 $135,000
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $60,020 - $131,696
660 Added 90.29%
1,391 $126,000
Q1 2023

Apr 19, 2023

SELL
$132.34 - $159.14 $3,440 - $4,137
-26 Reduced 3.43%
731 $116,000
Q3 2022

Oct 21, 2022

BUY
$95.28 - $116.93 $7,241 - $8,886
76 Added 11.16%
757 $75,000
Q2 2022

Aug 02, 2022

BUY
$103.24 - $121.81 $5,987 - $7,064
58 Added 9.31%
681 $76,000
Q1 2022

May 02, 2022

BUY
$93.1 - $112.54 $40,219 - $48,617
432 Added 226.18%
623 $69,000
Q3 2021

Nov 09, 2021

BUY
$84.42 - $106.62 $16,124 - $20,364
191 New
191 $18,000
Q1 2021

Apr 28, 2021

SELL
$67.06 - $75.82 $22,129 - $25,020
-330 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$49.46 - $64.78 $16,321 - $21,377
330 New
330 $20,000
Q2 2018

Jul 26, 2018

SELL
$44.29 - $50.42 $2,745 - $3,126
-62 Closed
0 $0
Q4 2017

Jan 31, 2018

BUY
$47.53 - $53.73 $2,946 - $3,331
62
62 $3,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $188B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jfs Wealth Advisors, LLC Portfolio

Follow Jfs Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.